Skinzone Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-12-2024
- Paid Up Capital ₹ 0.50 M
as on 05-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Skinzone Pharmaceuticals India
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Kadambala, Vara Bikkasani, and Venkata Sistla serve as directors at the Company.
- CIN/LLPIN
U24304MH2020PTC342553
- Company No.
342553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skinzone Pharmaceuticals India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Kadambala  | Director | 24-Jul-2020 | Current |
| Vara Bikkasani | Director | 24-Jul-2020 | Current |
| Venkata Sistla | Director | 15-Oct-2022 | Current |
Financial Performance of Skinzone Pharmaceuticals India.
Enhance accessibility to Skinzone Pharmaceuticals India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Skinzone Pharmaceuticals India?
Unlock access to Skinzone Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dermazone Pharmaceuticals Private LimitedActive 4 years 6 monthsVenkata Kadambala, Vara Bikkasani and 1 more are mutual person
Cosmania Healthcare Solutions Private LimitedActive 1 year 8 monthsVenkata Kadambala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skinzone Pharmaceuticals India?
Skinzone Pharmaceuticals India has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skinzone Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skinzone Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
